UBS Group
VINCU

UBS Group’s Vincerx Pharma, Inc. Unit VINCU Stock Holding History

UBS Group’s Portfolio VINCU Stock Details VINCU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-260
Closed -$7K – 10446
2021
Q1 		$7K Buy
260
+150
+136% +$4.13K ﹤0.01% 8209
2020
Q4 		$2K Buy
+110
New +$2.12K ﹤0.01% 8185

UBS Group's VINCU Position: Q2 2021 in Review

UBS Group sold out of Vincerx Pharma, Inc. Unit (VINCU) in Q2 2021, closing a stake of 260 shares — an estimated $7K sold.

UBS Group first reported a position in VINCU in Q4 2020 and held it in 2 quarters. The position peaked at $7K in Q1 2021. 0 funds tracked by Wall St. Rank hold VINCU as of Q2 2021.

  • UBS Group reported no remaining Vincerx Pharma, Inc. Unit position as of Q2 2021 after selling out during the quarter.
  • UBS Group sold 260 Vincerx Pharma, Inc. Unit shares in Q2 2021, an estimated $7K.
  • UBS Group first reported a position in Vincerx Pharma, Inc. Unit in Q4 2020 and held it in 2 quarters.
  • UBS Group's Vincerx Pharma, Inc. Unit position peaked at $7K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Unit as of Q2 2021.

Based on UBS Group's 13F filing for Q2 2021, filed 13 Aug 2021.